Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-08-20
DOI
10.1016/j.annonc.2021.08.1988
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors – An analysis of 2765 patients from neoadjuvant clinical trials
- (2021) Sonia L. Villegas et al. EUROPEAN JOURNAL OF CANCER
- Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
- (2020) Kimberly H. Allison et al. JOURNAL OF CLINICAL ONCOLOGY
- Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
- (2019) H J Burstein et al. ANNALS OF ONCOLOGY
- Low Estrogen Receptor (ER)–Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy
- (2018) Alessandra Landmann et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- High incidence of germlineBRCAmutation in patients with ER low-positive/PR low-positive/HER-2neunegative tumors
- (2015) Rachel A. Sanford et al. CANCER
- Low ER+ Breast Cancer
- (2014) Nika C. Gloyeske et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Which threshold for ER positivity? a retrospective study based on 9639 patients
- (2014) M. Yi et al. ANNALS OF ONCOLOGY
- Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
- (2014) Gunter von Minckwitz et al. LANCET ONCOLOGY
- Personalized adjuvant therapies: Lessons from the past
- (2013) Aron Goldhirsch BREAST
- Effect of ASCO/CAP Guidelines for Determining ER Status on Molecular Subtype
- (2012) Brenda Deyarmin et al. ANNALS OF SURGICAL ONCOLOGY
- Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
- (2012) Takayuki Iwamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial
- (2012) Michael Untch et al. LANCET ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More